N-[5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]pyridin-2-yl]-N'-(pyrimidin-2-yl)propane-1,3-diamine | 820223-05-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-[5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]pyridin-2-yl]-N'-(pyrimidin-2-yl)propane-1,3-diamine
• 英文别名: N-[5-chloro-4-[(4-chlorophenyl)sulfonyl-(2,5-difluorophenyl)methyl]pyridin-2-yl]-N'-pyrimidin-2-ylpropane-1,3-diamine
• CAS: 820223-05-0
• 化学式: C₂₅H₂₁Cl₂F₂N₅O₂S
• 分子量: 564.443
• InChiKey: CIEUKDDKSVYVAO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  37
• 可旋转键数：
  10
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  105
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  2-氯嘧啶 、 N-[5-chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]pyridin-2-yl]propane-1,3-diamine dihydrochloride 在 三乙胺 作用下， 以 1,4-二氧六环 为溶剂， 反应 19.0h， 以65%的产率得到N-[5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]pyridin-2-yl]-N'-(pyrimidin-2-yl)propane-1,3-diamine
  参考文献：
  名称：

  EP1640366

  摘要：

  公开号：

文献信息

• Morpholine derivatives
  申请人：Kubota Hideki

  公开号：US20060241302A1

  公开（公告）日：2006-10-26

  Provided is a compound capable of inhibiting production or secretion of β amyloid protein. A compound represented by the following formula (1): (wherein, R 1 represents a heterocyclic group which may have a substituent, R 2 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R 3 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R 4 represents a hydrogen atom or a C 1-6 alkyl group, and X represents —S—, —SO— or —SO 2 —); an N-oxide or S-oxide thereof; a salt thereof; or a solvate thereof; and a medicament containing any of them.

  提供了一种能够抑制β淀粉样蛋白产生或分泌的化合物。该化合物由以下公式（1）表示：（其中，R1代表可能具有取代基的杂环基团，R2代表可能具有取代基或杂环基团的环烃基团，R3代表可能具有取代基或杂环基团的环烃基团，R4代表氢原子或C1-6烷基基团，X代表—S—、—SO—或—SO2—）；其N-氧化物或S-氧化物；其盐；或其溶剂化物；以及含有任何一种的药物。
• Heterocyclic methyl sulfone derivative
  申请人：Daiichi Pharmaceutical Co., Ltd.

  公开号：US07932271B2

  公开（公告）日：2011-04-26

  Provided is a compound capable of inhibiting production or secretion of β amyloid protein. A compound represented by the following formula (1): (wherein, R1 represents a heterocyclic group which may have a substituent, R2 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R3 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R4 represents a hydrogen atom or a C1-6 alkyl group, and X represents —S—, —SO— or —SO2—); an N-oxide or S-oxide thereof; a salt thereof; or a solvate thereof; and a medicament containing any of them.

  提供了一种化合物，能够抑制β淀粉样蛋白的产生或分泌。该化合物由以下式子（1）表示：（其中，R1代表一个杂环基团，可以具有取代基；R2代表一个环烃基团，可以具有取代基或一个杂环基团，可以具有取代基；R3代表一个环烃基团，可以具有取代基或一个杂环基团，可以具有取代基；R4代表一个氢原子或一个C1-6烷基基团，X代表—S—，—SO—或—SO2—）；其N-氧化物或S-氧化物；其盐；或其溶剂化物；以及含有它们的药物。
• HETEROCYCLIC METHYL SULFONE DERIVATIVE
  申请人：DAIICHI PHARMACEUTICAL CO., LTD.

  公开号：EP1640366A1

  公开（公告）日：2006-03-29

  Provided is a compound capable of inhibiting production or secretion of β amyloid protein. A compound represented by the following formula (1): (wherein, R1 represents a heterocyclic group which may have a substituent, R2 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R3 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R4 represents a hydrogen atom or a C1-6 alkyl group, and X represents -S-,-SO- or -SO2-) an N-oxide or S-oxide thereof; a salt thereof; or a solvate thereof; and a medicament containing any of them.

  本发明提供了一种能够抑制β淀粉样蛋白产生或分泌的化合物。 由下式（1）代表的化合物： (其中，R1代表可具有取代基的杂环基团，R2代表可具有取代基的环烃基团或可具有取代基的杂环基团，R3代表可具有取代基的环烃基团或可具有取代基的杂环基团，R4代表氢原子或C1-6烷基，X代表-S-、-SO-或-SO2-)其N-氧化物或S-氧化物；其盐；或其溶液；以及含有其中任何一种的药物。
• US7932271B2
  申请人：——

  公开号：US7932271B2

  公开（公告）日：2011-04-26